Antiviral Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065126
  • May 2021
  • Pharmaceuticals
  • 128 Pages
The Antiviral Drugs Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Merck & Co., Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Mylan N.V., Dr. Reddy\'s Laboratories Ltd, Cipla Inc., Aurobindo Pharma
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Antiviral Drugs market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Antiviral Drugs market is expected to attain Pre COVID-19 levels by mid-2022.

Antiviral Drugs Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Antiviral Drugs market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Antiviral Drugs Market Competitive and Premeditated Analysis
In the Antiviral Drugs report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Antiviral Drugs research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Antiviral Drugs Market:
The Antiviral Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Merck & Co., Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Mylan N.V., Dr. Reddy\'s Laboratories Ltd, Cipla Inc., Aurobindo Pharma

The Antiviral Drugs market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Antiviral Drugs Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Antiviral Drugs market:
by Mechanism of Action
Protease Inhibitors
Nucleotide Polymerase Inhibitor
Reverse Transcriptase Inhibitors
Others
Application
Hepatitis
HIV
Influenza
Herpes
Others
Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies

Regional Analysis of the Antiviral Drugs market:
The Antiviral Drugs market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Antiviral Drugs report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Antiviral Drugs market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Antiviral Drugs market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Antiviral Drugs market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Antiviral Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Antiviral Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Antiviral Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Antiviral Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Antiviral Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Mylan N.V.
  • Dr. Reddy's Laboratories Ltd
  • Cipla Inc.
  • Aurobindo Pharma
  • Protease Inhibitors
  • Nucleotide Polymerase Inhibitor
  • Reverse Transcriptase Inhibitors
  • Others
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Antiviral Drugs Market Snapshot
          2.1.1. Global Antiviral Drugs Market By Mechanism of Action,2019
               2.1.1.1.Protease Inhibitors
               2.1.1.2.Nucleotide Polymerase Inhibitor
               2.1.1.3.Reverse Transcriptase Inhibitors
               2.1.1.4.Others
          2.1.2. Global Antiviral Drugs Market By Distribution Channel,2019
               2.1.2.1.Hospital pharmacies
               2.1.2.2.Retail pharmacies
               2.1.2.3.Online pharmacies
          2.1.3. Global Antiviral Drugs Market By End-use,2019
          2.1.4. Global Antiviral Drugs Market By Geography,2019

3. Global Antiviral Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Mechanism of Action, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Mechanism of Action, 2020
     4.2. Global Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028

5. Global Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Antiviral Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Antiviral Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Antiviral Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028
          7.2.3. North America Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Antiviral Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Antiviral Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028
          7.3.3. Europe Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Antiviral Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Antiviral Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028
          7.4.3. Asia Pacific Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Antiviral Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Antiviral Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028
          7.5.3. Latin America Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Antiviral Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Antiviral Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Antiviral Drugs Market Size (US$), By Mechanism of Action, 2018 – 2028
          7.6.3. MEA Antiviral Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Antiviral Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Antiviral Drugs Providers
        8.4.1 F. Hoffmann-La Roche Ltd
                8.4.1.1 Business Description
                8.4.1.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.1.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.1.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.1.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.2 GlaxoSmithKline plc.
                8.4.2.1 Business Description
                8.4.2.2 GlaxoSmithKline plc. Geographic Operations
                8.4.2.3 GlaxoSmithKline plc. Financial Information
                8.4.2.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.2.5 GlaxoSmithKline plc. Key Developments
        8.4.3 Merck & Co., Inc.
                8.4.3.1 Business Description
                8.4.3.2 Merck & Co., Inc. Geographic Operations
                8.4.3.3 Merck & Co., Inc. Financial Information
                8.4.3.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.3.5 Merck & Co., Inc. Key Developments
        8.4.4 Gilead Sciences, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Gilead Sciences, Inc. Geographic Operations
                8.4.4.3 Gilead Sciences, Inc. Financial Information
                8.4.4.4 Gilead Sciences, Inc. Product Positions/Portfolio
                8.4.4.5 Gilead Sciences, Inc. Key Developments
        8.4.5 Bristol-Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol-Myers Squibb Company Financial Information
                8.4.5.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol-Myers Squibb Company Key Developments
        8.4.6 Johnson & Johnson Services, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Johnson & Johnson Services, Inc. Geographic Operations
                8.4.6.3 Johnson & Johnson Services, Inc. Financial Information
                8.4.6.4 Johnson & Johnson Services, Inc. Product Positions/Portfolio
                8.4.6.5 Johnson & Johnson Services, Inc. Key Developments
        8.4.7 Mylan N.V.
                8.4.7.1 Business Description
                8.4.7.2 Mylan N.V. Geographic Operations
                8.4.7.3 Mylan N.V. Financial Information
                8.4.7.4 Mylan N.V. Product Positions/Portfolio
                8.4.7.5 Mylan N.V. Key Developments
        8.4.8 Dr. Reddy's Laboratories Ltd
                8.4.8.1 Business Description
                8.4.8.2 Dr. Reddy's Laboratories Ltd Geographic Operations
                8.4.8.3 Dr. Reddy's Laboratories Ltd Financial Information
                8.4.8.4 Dr. Reddy's Laboratories Ltd Product Positions/Portfolio
                8.4.8.5 Dr. Reddy's Laboratories Ltd Key Developments
        8.4.9 Cipla Inc.
                8.4.9.1 Business Description
                8.4.9.2 Cipla Inc. Geographic Operations
                8.4.9.3 Cipla Inc. Financial Information
                8.4.9.4 Cipla Inc. Product Positions/Portfolio
                8.4.9.5 Cipla Inc. Key Developments
        8.4.10 Aurobindo Pharma
                8.4.10.1 Business Description
                8.4.10.2 Aurobindo Pharma Geographic Operations
                8.4.10.3 Aurobindo Pharma Financial Information
                8.4.10.4 Aurobindo Pharma Product Positions/Portfolio
                8.4.10.5 Aurobindo Pharma Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Antiviral Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Antiviral Drugs Market Revenue, By Mechanism of Action, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Antiviral Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Antiviral Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Antiviral Drugs Market Revenue, By Mechanism of Action, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Antiviral Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Antiviral Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Antiviral Drugs Market Revenue, By Mechanism of Action, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Antiviral Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Antiviral Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Antiviral Drugs Market Revenue, By Mechanism of Action, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Antiviral Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Antiviral Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Antiviral Drugs Market Revenue, By Mechanism of Action, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Antiviral Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Antiviral Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Antiviral Drugs: Market Segmentation 
FIG. 2 Global Antiviral Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Antiviral Drugs Market, By Mechanism of Action, 2019 (US$ Mn) 
FIG. 5 Global Antiviral Drugs Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Antiviral Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Antiviral Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Antiviral Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Antiviral Drugs Providers, 2019
FIG. 11 Global Antiviral Drugs Market Revenue Contribution, By Mechanism of Action, 2019 & 2028 (Value %) 
FIG. 12 Global Antiviral Drugs Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Antiviral Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Antiviral Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Antiviral Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Antiviral Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Antiviral Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Antiviral Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Antiviral Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Antiviral Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Antiviral Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Antiviral Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Antiviral Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Antiviral Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Antiviral Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Antiviral Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Antiviral Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Antiviral Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Antiviral Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Antiviral Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Antiviral Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Antiviral Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Antiviral Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Antiviral Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Antiviral Drugs Market Value, By Country, 2018 – 2028
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Services, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dr. Reddy's Laboratories Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aurobindo Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Antiviral Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Antiviral Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Antiviral Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Antiviral Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Antiviral Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Antiviral Drugs Providers, 2016
FIG.  Global Antiviral Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Nucleotide Polymerase Inhibitor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Reverse Transcriptase Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antiviral Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Antiviral Drugs Market Value, 2018 – 2028, (US$ Mn)